A carregar...
Management of relapsed-refractory diffuse large B cell lymphoma
Relapsed-Refractory Diffuse Large B Cell Lymphoma (RR DLBCL), which accounts for approximately one-third of patients with DLBCL, remains a major cause of morbidity and mortality. Managing RR DLBCL continues to be a challenge to the treating hemato-oncologist. Salvage high-dose chemotherapy followed...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3961873/ https://ncbi.nlm.nih.gov/pubmed/24665451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.126531 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|